Skip to main content

Advertisement

SpringerLink
Log in

Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Silberstein EB. The problem of the patient with thyroglobulin elevation but negative iodine scintigraphy: the TENIS syndrome. Semin Nucl Med. 2011;41:113–20.

    Article  PubMed  Google Scholar 

  2. Hynes RO. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 2002;8:918–21.

    Article  PubMed  CAS  Google Scholar 

  3. Ferro-Flores G, Jiménez-Mancilla N, Morales-Avila E, Luna-Gutiérrez M, Ocampo-García B, De León-Rodríguez L. 177Lu-labeled monomeric, dimeric and multimeric RGD peptides for the therapy of tumors expressing α(ν)β(3) integrins. J Label Compd Radiopharm. 2012;55:140–8.

    Article  CAS  Google Scholar 

  4. Vatsa R, Shykla J, Mittal BR, Bhusari P, Sood A, Basher RK, et al. Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT imaging in thyroglobulin elevation with negative iodine scintigraphy. Clin Nucl Med. 2017;42:471–2.

    Article  PubMed  Google Scholar 

Download references

Funding

The present study did not receive any funding.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Nehru Hospital, Postgraduate Institute of Medical Education & Research (PGIMER), Ground Floor, A block, Chandigarh, 160012, India

    Ashwin Singh Parihar, Ashwani Sood, Rajender Kumar, Priya Bhusari, Jaya Shukla & Bhagwant Rai Mittal

Authors
  1. Ashwin Singh Parihar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashwani Sood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rajender Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Priya Bhusari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jaya Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bhagwant Rai Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bhagwant Rai Mittal.

Ethics declarations

Conflict of interest

Ashwin Singh Parihar declares that he has no conflict of interest.

Ashwani Sood declares that he has no conflict of interest.

Rajender Kumar declares that he has no conflict of interest.

Priya Bhusari declares that she has no conflict of interest.

Jaya Shukla declares that she has no conflict of interest.

Bhagwant Rai Mittal declares that he has no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parihar, A.S., Sood, A., Kumar, R. et al. Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS. Eur J Nucl Med Mol Imaging 45, 1836–1837 (2018). https://doi.org/10.1007/s00259-018-4036-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-4036-x

Keywords

Search

Navigation